The incorporation of SPECT functional lung imaging into inverse radiotherapy planning for non-small cell lung cancer

J. A. Christian, M. Partridge, E. Nioutsikou, G. Cook, H. A. McNair, B. Cronin, F. Courbon, J. L. Bedford, M. Brada

Research output: Contribution to journalArticlepeer-review

99 Citations (Scopus)

Abstract

Background and purpose: Patients with non-small cell lung cancer (NSCLC) often have inhomogeneous lung perfusion. Radiotherapy planning computed tomography (CT) scans have been accurately co-registered with lung perfusion single photon emission computed tomography (SPECT) scans to design radiotherapy treatments which limit dose to healthy 'perfused' lung. Patients and methods: Patients with localised NSCLC had CT and SPECT scans accurately co-registered in the planning system. The SPECT images were used to define a volume of perfused 'functioning' lung (FL). Inverse planning software was used to create 3D-conformal plans, the planning objective being either to minimise the dose to whole lungs (WL) or to minimise the dose to FL. Results: Four plans were created for each of six patients. The mean difference in volume between WL and FL was 1011.7 cm(3) (range 596.2-1581.1 cm(3)). One patient with bilateral upper lobe perfusion deficits had a 16% reduction in FLV20 (the percentage volume of functioning lung receiving >= 20 Gy). The remaining patients had inhomogeneous perfusion deficits such that inverse planning was not able to sufficiently optimise beam angles to avoid functioning lung. Conclusion: SPECT perfusion images can be accurately co-registered with radiotherapy planning CT scans and may be helpful in creating treatment plans for patients with large perfusion deficits.
Original languageEnglish
Pages (from-to)271-277
Number of pages7
JournalRadiotherapy and Oncology
Volume77
Issue number3
DOIs
Publication statusPublished - Dec 2005

Fingerprint

Dive into the research topics of 'The incorporation of SPECT functional lung imaging into inverse radiotherapy planning for non-small cell lung cancer'. Together they form a unique fingerprint.

Cite this